Cells4life Stem Cells
Stem cells have the ability to transform into a wide range of tissues and Cells4life stem cells store this blood, with the ability to regenerate various types of organs, making it one of the most important cell types, there are immense possibilities of using this cell type in the future.
Types and Therapies
Cells4Life has the highest performing cord blood processing system in the world called TotiCyte which can deliver 100% – 400% more stem cells than any other method. It delivers up to 5 times more viable cells at the point of treatment. More stem cell harvest is useful as then it can be used when the child is older and also gives the option of having more therapies.
Since it is not fully understood which cells can be used and which can’t, it is beneficial to store many types of stem cells as possible. Umbilical Cord blood contains mainly three types of stem cells namely; hemopoietic stem cells, mesenchymal stem cells and embryonic-like stem cells which are very small.
Hematopoietic Stem Cells
Can transform into various blood cells such as red blood cells and white blood cells which can be used for many therapies in blood-related disorders. Mesenchymal stem cells can transform into bone tissue, cartilage tissue, connective tissue, adipose tissue, muscle, nerves, and tendons.
It is recognized that umbilical cord blood stem cells can treat more than 80 diseases. Because it can recover 3 types of cells, the types of therapies that can offer also increase. Hemopoietic stem cells can be used for metabolic disorders such as Hurler syndrome, blood cancers such as leukemia, lymphoma, myeloma, tumors such as neuroblastoma and blood disorders such as Sickle cell anemia, Aplastic anemia, and Fanconi anemia.
These cells can also be used to rebuild the immune system if the child’s own immune system is damaged by chemotherapy due to cancer. Can be used for novel therapies such as autism, cerebral palsy, hearing loss, Parkinson’s disease, Alzheimer’s disease, brain injury, diabetes, spinal cord injury, stroke, burns and multiple sclerosis. Mesenchymal stem cells can also be used for regenerative therapies that are used for regenerating human tissues and organs which have malfunctioned. It is estimated that 48% of cord blood bank releases are for this regenerative therapy.
Best possible protection
The advantage it has Cells4Life is unique in its ability to protect the umbilical cord blood sample in case of a disaster. It divides the samples into 2 and stores them at 2 geographically separate locations so that if one facility is affected in a disaster there is another sample that can be useful offering the highest protection and security for the sample. The cord blood is also stored in multiple samples so that one sample can be used while the remaining cells can be used in the future therapies.
Cells4life also has taken precautions to ensure the continuity of storage in case of a failure of the company. It has stored sufficient funds in an escrow account in order to cover the expenses for the stored samples for many years to come. This has been done under agreement with an HTA licensed facility underwritten by Lloyd’s of London brokerage. Cells4Life also has experienced laboratory workers and scientists who can ensure the quality of the sample.
Stem cell expenses insurance
In case of a need arises to use the stem cells for treatment, Stem4Life has offered an insurance scheme so that there will be sufficient funds to be used for the required therapy. As the novel stem cell treatments can be very expensive, this has provided a way for parents to have their children treated. It also has many insurance schemes called +protect and +protect extra.
In +protect, it covers the treatment and non-treatment related expenses of the child and family members if they needed treatment. It can cover hospital bill, drugs, medical staff and the cost for searching alternative samples if it’s not matching. It can also cover expenses for traveling, accommodation and home aid.
In +protect extra, an additional amount of money is paid if the child is diagnosed with cerebral palsy which can be used for various clinical trial treatments which have promising results.